Execruit noted that Kyowa Kirin named its first non-Japanese CEO.
Public source
Publisher name
Public post
2026 is becoming one of the biggest CEO turnover years biopharma has seen in a while. Sanofi, Takeda, GSK, CSL, Cipla, Kyowa Kirin - all naming new CEOs within months of…
Company
Execruit
Executive Search for Hard-to-Reach Biotech & Pharma Scientific, Commercial, & C-Suite Talent Across EU/US/APAC
- Industry
- Staffing and Recruiting
- Location
- Basel, CH
- Company size
- 1 employee
About Execruit
Execruit is a Biopharma-focused executive and professional search firm built by industry insiders. Our team brings scientific depth and hands-on experience across R&D, commercial, and corporate development functions at leading global pharmaceutical companies giving us a working understanding of biopharma leadership that goes beyond traditional search. We advise boards and executive teams across the biopharmaceutical sector on senior leadership and critical talent appointments, leadership development, and CEO succession planning. Our core mandate is building high-impact teams for biotechs and pharmaceutical companies: identifying executives, functional leaders, and hard-to-find scientific talent who drive scientific innovation, clinical progress, and long-term commercial growth. We operate across multiple therapeutic areas with reach across the entire development life cycle from early discovery and IND-enabling research through global commercialisation and a clear view of the leadership shifts each stage demands. Our client base spans the full scale of the industry: from Series A and early-stage biotechs building their founding leadership teams, to publicly listed multinational pharmaceutical companies managing global executive succession. Across that range, we work directly with boards, founders, investors, executives, and hiring managers to place leaders who fit not just the role, but the science, strategy, and stage of the business. Leadership decisions in this industry shape pipelines, regulatory outcomes, and ultimately patient lives. Our work is built to reflect that delivering leaders equipped for long-term impact, not just candidates who meet a specification.
See moreLatest activity
Latest activity from Execruit
5 signals
People
Execruit noted that Sanofi's Paul Hudson was replaced by Belén Garijo after a restructuring push that didn't deliver fast enough.
People
Execruit noted that CSL's CEO departed abruptly this year amid a 40% share price drop and staff cuts.
People
Execruit noted that Vaxxas brought in a leader specifically to run commercialisation rather than early-stage R&D.
Discover more
Similar signals
Similar public activity from other companies.
People
TSE Executive Search
TSE Executive Search appointed an Asset Acquisition and Strategy Lead.
People
Leaman Life Sciences
Leaman Life Sciences made 6 executive hires across Clinical Development, Medical Affairs, CMC, Commercial, Regulatory Strategy and Preclinical Development for a clinical-stage biopharma company.
People
BioTalent
BioTalent helped a Swiss biotech secure board-level guidance without immediate compensation by engaging industry professionals and acting board advisors within a five-stage process.
People
K-Recruiting Life Sciences
K-Recruiting Life Sciences appointed Amber O'Donnell, Audrey T. and Trevor Golden as Strategic Staffing & FSP, Sales and Recruiting.
People
Quiddity Talent Solutions